L. RHAMNOSUS LB3
Live / Registered — Registered and renewed (as of 29 Oct 2025)
What this means for you
Registered since 18 Aug 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Aug 2025).
Record
- Serial number
- 85945258
- Registration number
- 4795700
- Mark type
- Stylized text
- Filed
- 29 May 2013
- Published for opposition
- 12 Nov 2013
- Registered
- 18 Aug 2015
- Next maintenance due
- 18 Aug 2025
- Attorney of record
- William A. McKenna
Goods and services
- Class 001 — Chemicals: Bacterial preparations for digestive, immune and mitochondria health derived from a strain of Lactobacillus rhamnosus and from digest components and lysates thereof, for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products; live bacterial culture preparations derived from a strain of Lactobacillus rhamnosus for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products; bacterial digest components derived from a strain of Lactobacillus rhamnosus for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products; components from the digest of bacteria derived from a strain of Lactobacillus rhamnosus for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products; lysate or cell component preparations derived from a strain of Lactobacillus rhamnosus for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products; microbial structural components crude and purified, cell metabolite compositions obtained by physical, mechanical or enzyme treatments and derived from a strain of Lactobacillus rhamnosus for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, human foods, cosmetics, animal foods and health products
- Class 005 — Pharmaceuticals: Nutritional supplements for human and animal health, namely, microbial structural components crude and purified, cell metabolite compositions obtained by physical, mechanical or enzyme treatments, and microbial structural components derived from a strain of Lactobacillus rhamnosus
Owner
- Vivolac Cultures Corporation, Greenfield, IN, US
- Vivolac Cultures Corporation, Greenfield, IN, US
- Vivolac Cultures Corporation, Indianapolis, IN, US
Prosecution history
- 29 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Oct 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 29 Oct 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 18 Aug 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Nov 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Aug 2021 — TEAS SECTION 8 & 15 RECEIVED
- 18 Aug 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Aug 2015 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jul 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jul 2015 — STATEMENT OF USE PROCESSING COMPLETE